Geneos Wealth Management’s VERITIV CORPORATION VRTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-59
Closed -$9.96K 2198
2023
Q3
$9.96K Hold
59
﹤0.01% 1571
2023
Q2
$7.41K Hold
59
﹤0.01% 1649
2023
Q1
$7.97K Hold
59
﹤0.01% 1608
2022
Q4
$7.18K Hold
59
﹤0.01% 1621
2022
Q3
$5K Hold
59
﹤0.01% 1712
2022
Q2
$6K Hold
59
﹤0.01% 2155
2022
Q1
$7K Hold
59
﹤0.01% 2258
2021
Q4
$7K Hold
59
﹤0.01% 2323
2021
Q3
$5K Buy
+59
New +$4.51K ﹤0.01% 2481
2017
Q3
Sell
-23
Closed -$1K 2162
2017
Q2
$1K Sell
23
-9
-28% -$413 ﹤0.01% 2050
2017
Q1
$1K Sell
32
-1
-3% -$55 ﹤0.01% 2041
2016
Q4
$1K Hold
33
﹤0.01% 2025
2016
Q3
$1K Buy
33
+3
+10% +$139 ﹤0.01% 1950
2016
Q2
$1K Hold
30
﹤0.01% 1785
2016
Q1
$1K Buy
+30
New +$988 ﹤0.01% 1769

Other funds holding VRTV

Geneos Wealth Management's VRTV Position: Q4 2023 in Review

Geneos Wealth Management sold out of VERITIV CORPORATION (VRTV) in Q4 2023, closing a stake of 59 shares — an estimated $9.96K sold.

Geneos Wealth Management first reported a position in VRTV in Q1 2016 and held it in 15 quarters. The position peaked at $9.96K in Q3 2023. 3 funds tracked by Wall St. Rank hold VRTV as of Q4 2023.

  • Geneos Wealth Management reported no remaining VERITIV CORPORATION position as of Q4 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 59 VERITIV CORPORATION shares in Q4 2023, an estimated $9.96K.
  • Geneos Wealth Management first reported a position in VERITIV CORPORATION in Q1 2016 and held it in 15 quarters.
  • Geneos Wealth Management's VERITIV CORPORATION position peaked at $9.96K in Q3 2023.
  • 3 funds tracked by Wall St. Rank held VERITIV CORPORATION as of Q4 2023.

Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.